Stay updated on Pembrolizumab in Refractory Meningioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.

Latest updates to the Pembrolizumab in Refractory Meningioma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows an updated revision tag, changing from v3.6.4 to v3.6.5, indicating a backend/template update for the study page without altering study data or visible content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page shows revision v3.6.4, replacing v3.6.3, indicating an internal update. The study information and layout remain unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3, reflecting a newer version of the study record page. This update signifies ongoing maintenance of the page's documentation.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now reflects that recruitment has ended by noting 'No longer looking for participants,' signaling no active enrollment for this study. In addition, the page adds help-related links (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label while updating the revision metadata to v3.6.0.SummaryDifference0.6%

- Check77 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's content or metadata. This change does not modify the substantive study details or results.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision tag on the page updated from v3.5.3 to v3.5.4, signaling a new deployment of the page. This update does not change the trial details or related information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Refractory Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.